Medical Health & Life Science Research News

The global peptide therapeutics market explored in latest research

Medical Market Research

Therapeutic peptides have established importance in the treatment of numerous diseases such as nervous system disorders, gastrointestinal disorders, prostrate, breast and ovarian cancers. Peptides carrying antagonists and agonists receptors in nature are progressively being tested for their effectiveness in cancer treatment.

- Advertising -

Global peptide therapeutics market is projected to register a CAGR of 8.2% over the forecast period i.e. 2016-2023. Moreover, the global peptide therapeutics market is anticipated to reach at noteworthy revenue of USD 26.2 Billion by 2023.

The market is expected to expand on the back of increasing investment in healthcare sector by the government authorities.

Peptides are commonly known as amide bonds. These are used to treat blood-based disorders, certain types of cancers, chronic ailments, CNS (central nervous system) disorders, and cardiovascular & respiratory anomalies.

- Advertising -

Growing importance of peptide therapeutics in the pharmaceutical market may significantly contribute to overall demand during the forecast period (2016 to 2023). However, changing customer needs and lack of regulatory standards hinder industry progress.

 Increasing Geriatric Population

Increase in aging population across the globe is believed to trigger the prevalence of diseases such as cardiac, cardiovascular and osteoporosis which is likely to increase the burden on emerging economies, thus intensifying the demand for peptide therapeutics so as to reduce the burden and minimize the health expenditure.

Report: www.researchnester.com/sample-request/2/rep-id-180

Rising Healthcare Expenditure

Rising biotech companies and increasing healthcare spending by the government authorities, rising prevalence of cancer and nervous system disorders are some of the factors expected to fuel the demand for peptide therapeutics in near future. Furthermore, rising awareness towards peptide therapeutics and introduction of favorable re-imbursement policies by the government organizations across the globe is envisioned to bolster the growth of the global peptide therapeutics market in next upcoming years.

Although, high cost of peptide therapeutics is expected to limit the growth of peptide therapeutics market by the end of 2023. Moreover, lack of awareness in under-developed nations is hindering the demand for peptide therapeutics.

The report titled “Peptide Therapeutics Market: Global Market Size, Demand Analysis & Opportunity Outlook 2023delivers detailed overview of the global peptide therapeutics market in terms of market segmentation by application, by route of administration, by Synthesis, by drugs, by type of molecule, by end-user and by region.   

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Report: www.researchnester.com/toc-request/1/rep-id-180

This report also provides the existing competitive scenario of some of the key players of the global peptide therapeutics market which includes company profiling of Teva Pharmaceutical Ltd., Novartis AG, Bachem Holdings AG, Sanofi, Pfizer Inc., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., F. Hoffmann-La Roche Ltd.

and Takeda Pharmaceutical Industries Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments.

On the whole, the report depicts detailed overview of the global peptide therapeutics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment.

We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Report: www.researchnester.com/rep-id-180

 

News From

Research Nester Pvt Ltd - Market Research Consulting and Industry ReportsResearch Nester Pvt Ltd
Category: Market Research Publishers and RetailersCompany about: Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wis ...